128 related articles for article (PubMed ID: 2029075)
1. Long-term effects of mass screening for neuroblastoma in infancy.
Sawada T; Matsumura T; Kawakatsu H; Sugimoto T; Kuroda H; Hosoi H; Michihata T; Saida T; Hino T
Am J Pediatr Hematol Oncol; 1991; 13(1):3-7. PubMed ID: 2029075
[TBL] [Abstract][Full Text] [Related]
2. Neuroblastoma. Mass screening for early detection and its prognosis.
Sawada T; Kidowaki T; Sakamoto I; Hashida T; Matsumura T; Nakagawa M; Kusunoki T
Cancer; 1984 Jun; 53(12):2731-5. PubMed ID: 6722733
[TBL] [Abstract][Full Text] [Related]
3. Improvement in prognosis of neuroblastoma through mass population screening.
Naito H; Sasaki M; Yamashiro K; Takeda T; Takasugi N; Uchino J; Hata Y
J Pediatr Surg; 1990 Feb; 25(2):245-8. PubMed ID: 2303994
[TBL] [Abstract][Full Text] [Related]
4. Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group.
Sawada T; Hirayama M; Nakata T; Takeda T; Takasugi N; Mori T; Maeda K; Koide R; Hanawa Y; Tsunoda A
Lancet; 1984 Aug; 2(8397):271-3. PubMed ID: 6146820
[TBL] [Abstract][Full Text] [Related]
5. The relationship between homovanillic/vanillylmandelic acid ratios and prognosis in neuroblastoma.
Nishi M; Miyake H; Takeda T; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hirama T; Ishikawa Y; Kudoh T; Azuma H; Takase A
Oncol Rep; 1998; 5(3):631-3. PubMed ID: 9538165
[TBL] [Abstract][Full Text] [Related]
6. Past and future of neuroblastoma screening in Japan.
Sawada T
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
[TBL] [Abstract][Full Text] [Related]
8. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Yonemori H; Hanai J; Kikuchi Y; Takasugi N
Jpn J Clin Oncol; 1994 Oct; 24(5):247-51. PubMed ID: 7967103
[TBL] [Abstract][Full Text] [Related]
9. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
10. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S
J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545
[TBL] [Abstract][Full Text] [Related]
11. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
[TBL] [Abstract][Full Text] [Related]
12. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma in children: a 10-year experience in Saudi Arabia.
al-Mulhim I
J Trop Pediatr; 1998 Apr; 44(2):77-80. PubMed ID: 9604593
[TBL] [Abstract][Full Text] [Related]
14. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
[TBL] [Abstract][Full Text] [Related]
15. Mass screening for neuroblastoma in Japan.
Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
[TBL] [Abstract][Full Text] [Related]
16. Incidence of neuroblastoma in infancy in Japan.
Sawada T; Kidowaki T; Sugimoto T; Kusunoki T
Med Pediatr Oncol; 1984; 12(2):101-3. PubMed ID: 6700544
[TBL] [Abstract][Full Text] [Related]
17. Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Yamashiro K; Takasugi N; Hanai J; Kawai T
Eur J Pediatr; 1990 Sep; 149(12):859-61. PubMed ID: 2226572
[TBL] [Abstract][Full Text] [Related]
18. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
[TBL] [Abstract][Full Text] [Related]
19. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
Suita S
J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
[TBL] [Abstract][Full Text] [Related]
20. Decrease in childhood neuroblastoma death in Japan.
Hanawa Y; Sawada T; Tsunoda A
Med Pediatr Oncol; 1990; 18(6):472-5. PubMed ID: 2233518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
